The inhibition of EGFR activation by Ang-(1–7) reported in this study is in agreement with our previous data showing that pretreatment with Ang-(1–7) prevents hyperglycemia-induced EGFR transactivation-dependent vascular complications [43]. This evidence concerns the gene EGFR and Hyperglycemia.